We are live on ! Find out more
ALNY icon

Alnylam Pharmaceuticals
ALNY

277 hedge funds and large institutions have $7.86B invested in Alnylam Pharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 65 funds opening new positions, 111 increasing their positions, 79 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

171% more first-time investments, than exits

New positions opened: 65 | Existing positions closed: 24

59% more call options, than puts

Call options by funds: $95.3M | Put options by funds: $59.8M

41% more repeat investments, than reductions

Existing positions increased: 111 | Existing positions reduced: 79

17% more funds holding

Funds holding: 237 → 277 (+40)

17% more capital invested

Capital invested by funds: $6.73B → $7.86B (+$1.13B)

8% less funds holding in top 10

Funds holding in top 10: 12 → 11 (-1)

Holders
277
Holders Change
+40
Holders Change %
+16.88%
% of All Funds
7.46%
Holding in Top 10
11
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-8.33%
% of All Funds
0.3%
New
65
Increased
111
Reduced
79
Closed
24
Calls
$95.3M
Puts
$59.8M
Net Calls
+$35.5M
Net Calls Change
+$14.3M

Top Buyers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$53.7M
2
State Street
State Street
Massachusetts
+$36.5M
3
First Trust Advisors
First Trust Advisors
Illinois
+$36M
4
TCIM
TIAA CREF Investment Management
New York
+$32.7M
5
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board
Ontario, Canada
+$27.2M

Top Sellers

1
Wellington Management Group
Wellington Management Group
Massachusetts
-$98.8M
2
CWAM
Columbia Wanger Asset Management
Illinois
-$42M
3
AWG
Alpha Wave Global
New York
-$39.9M
4
GGHC
Gilder Gagnon Howe & Co
New York
-$28.9M
5
JP Morgan Chase
JP Morgan Chase
New York
-$27.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
AWG
26
Alpha Wave Global
New York
$64.5M -$39.9M -334,000 -38%
AG
27
Artal Group
Luxembourg
$54.5M -$1.79M -15,000 -3%
Geode Capital Management
28
Geode Capital Management
Massachusetts
$52M +$2.79M +23,380 +6%
Northern Trust
29
Northern Trust
Illinois
$51M +$12.4M +103,393 +32%
TCIM
30
TIAA CREF Investment Management
New York
$49.5M +$32.7M +273,824 +197%
RI
31
RTW Investments
New York
$49.3M +$6.65M +55,621 +16%
Deutsche Bank
32
Deutsche Bank
Germany
$47.6M +$13.8M +115,854 +41%
Goldman Sachs
33
Goldman Sachs
New York
$46.2M -$25M -209,528 -35%
CCI
34
Columbus Circle Investors
$40.7M +$5.97M +49,971 +17%
American Century Companies
35
American Century Companies
Missouri
$38.5M +$7.79M +65,188 +25%
Bank of New York Mellon
36
Bank of New York Mellon
New York
$37.5M +$1.68M +14,024 +5%
CS
37
Credit Suisse
Switzerland
$37.2M +$4.54M +37,976 +14%
JP Morgan Chase
38
JP Morgan Chase
New York
$35.1M -$27.9M -233,727 -44%
BG
39
BlackRock Group
United Kingdom
$32.3M +$22.7M +189,632 +238%
GTP
40
Global Thematic Partners
New York
$27.9M -$18.3M -152,714 -40%
Canada Pension Plan Investment Board
41
Canada Pension Plan Investment Board
Ontario, Canada
$27.6M +$27.2M +227,400 +9,096%
VanEck Associates
42
VanEck Associates
New York
$24.7M +$2.22M +18,554 +10%
D.E. Shaw & Co
43
D.E. Shaw & Co
New York
$24.5M -$7.6M -63,585 -24%
Sumitomo Mitsui Trust Group
44
Sumitomo Mitsui Trust Group
Japan
$23.3M +$23.2M +194,116 New
TRSOTSOK
45
Teachers Retirement System of the State of Kentucky
Kentucky
$20.9M -$1.71M -14,279 -8%
TA
46
Teachers Advisors
New York
$19.2M +$7.52M +62,948 +65%
BA
47
BlackRock Advisors
Delaware
$19.1M +$1.66M +13,849 +9%
FC
48
FIC Capital
New York
$18.7M -$520K -4,350 -3%
TCM
49
TimesSquare Capital Management
New York
$18.4M +$2.77M +23,200 +18%
California Public Employees Retirement System
50
California Public Employees Retirement System
California
$17.5M +$5.62M +47,048 +48%
1
2
3 4 5

ALNY Hedge Fund Activity: Q2 2015 in Review

277 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Alnylam Pharmaceuticals (ALNY) for Q2 2015, worth a combined $7.86B — up 17% from $6.73B a quarter earlier.

Buyers outnumbered sellers: 65 funds opened new ALNY positions and 24 closed out — a net gain of 41 holders — while 111 added to existing stakes and 79 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $53.7M. The largest seller was Wellington Management Group, cutting an estimated $98.8M.

  • 277 institutional investors held Alnylam Pharmaceuticals (ALNY) as of Q2 2015, up from 237 in Q1 2015.
  • Funds reported $7.86B of Alnylam Pharmaceuticals stock for Q2 2015, up 17% quarter-over-quarter.
  • 65 funds opened new Alnylam Pharmaceuticals positions in Q2 2015 and 24 closed out, a net change of +41 holders.
  • The largest Alnylam Pharmaceuticals buyer in Q2 2015 was T. Rowe Price Associates, an estimated $53.7M added.
  • The largest Alnylam Pharmaceuticals seller in Q2 2015 was Wellington Management Group, an estimated $98.8M sold.

Based on aggregated 13F filings for Q2 2015.